As Seen In
Chronic Achilles Tendinosis Video Launched
Using Your Own Cells to Heal Tendon Injuries
RepliCel is developing an autologous cell-based product for the treatment of chronic Achilles tendinosis. This treatment has the potential to restore a patient’s chronic tendinosis to a completely healed state. To learn more watch our two minute video.
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.